JP2025512431A5 - - Google Patents
Info
- Publication number
- JP2025512431A5 JP2025512431A5 JP2024560536A JP2024560536A JP2025512431A5 JP 2025512431 A5 JP2025512431 A5 JP 2025512431A5 JP 2024560536 A JP2024560536 A JP 2024560536A JP 2024560536 A JP2024560536 A JP 2024560536A JP 2025512431 A5 JP2025512431 A5 JP 2025512431A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- tim
- car
- fusion protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263329551P | 2022-04-11 | 2022-04-11 | |
| US63/329,551 | 2022-04-11 | ||
| PCT/US2023/065619 WO2023201221A1 (en) | 2022-04-11 | 2023-04-11 | Recombinant tim-4 protein, chimeric antigen receptor (car) t cell delivery system and methods of making and using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512431A JP2025512431A (ja) | 2025-04-17 |
| JP2025512431A5 true JP2025512431A5 (enExample) | 2026-04-16 |
Family
ID=88330365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560536A Pending JP2025512431A (ja) | 2022-04-11 | 2023-04-11 | 組換えｔｉｍ－４タンパク質、キメラ抗原受容体（ｃａｒ）ｔ細胞送達システム及びそれを作製し、使用する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240156868A1 (enExample) |
| EP (1) | EP4508093A1 (enExample) |
| JP (1) | JP2025512431A (enExample) |
| KR (1) | KR20250005223A (enExample) |
| CN (1) | CN119301159A (enExample) |
| AU (1) | AU2023254190A1 (enExample) |
| CA (1) | CA3247489A1 (enExample) |
| WO (1) | WO2023201221A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240182540A1 (en) * | 2022-11-16 | 2024-06-06 | Duke University | Chimeric apoptotic signal targeting lymphocytes (tim-4 castl) and methods of making and using same |
| WO2025184206A1 (en) * | 2024-02-26 | 2025-09-04 | Duke University | Nkg2d bi-specific t cell engager and chimeric antigen receptor / t cell receptor cell delivery systems and methods of making and using same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0509139A (pt) * | 2004-03-24 | 2007-08-28 | Telos Fharmaceuticals Inc | composição, e, método de estimulação de uma resposta imune em um indivìduo, de tratamento profilático de uma doença, de melhoramento de um sinal ou sintoma associado com uma doença, de alvejamento de um tumor, de inibição do crescimento de tumor, e de detecção de um tumor |
| WO2013188693A1 (en) * | 2012-06-15 | 2013-12-19 | Imaginab, Inc. | Antigen binding constructs to cd3 |
| CA3109139A1 (en) * | 2018-08-30 | 2020-03-05 | HCW Biologics, Inc. | Methods of treating aging-related disorders |
| JP7868033B2 (ja) * | 2020-08-14 | 2026-06-01 | セロ・セラピューティクス・ホールディングス・インコーポレイテッド | キメラｔｉｍ受容体およびその使用 |
| WO2022036287A1 (en) * | 2020-08-14 | 2022-02-17 | Cero Therapeutics, Inc. | Anti-cd72 chimeric receptors and uses thereof |
-
2023
- 2023-04-11 CA CA3247489A patent/CA3247489A1/en active Pending
- 2023-04-11 KR KR1020247036967A patent/KR20250005223A/ko active Pending
- 2023-04-11 CN CN202380037773.4A patent/CN119301159A/zh active Pending
- 2023-04-11 JP JP2024560536A patent/JP2025512431A/ja active Pending
- 2023-04-11 WO PCT/US2023/065619 patent/WO2023201221A1/en not_active Ceased
- 2023-04-11 EP EP23789101.5A patent/EP4508093A1/en active Pending
- 2023-04-11 AU AU2023254190A patent/AU2023254190A1/en active Pending
- 2023-11-16 US US18/511,825 patent/US20240156868A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chao et al. | Fine epitope mapping of anti-epidermal growth factor receptor antibodies through random mutagenesis and yeast surface display | |
| CN112154157B (zh) | 抗ror1抗体及其用途 | |
| CN114539411B (zh) | 一种ror1抗体或其抗原结合片段 | |
| US8492520B2 (en) | Binding epitopes for G250 antibody | |
| US10919951B2 (en) | Chimeric antigen receptor | |
| JP2020517294A5 (enExample) | ||
| CN112074532B (zh) | 结合非天然NKG2D受体的非天然NKG2D配体的修饰的α1-α2结构域 | |
| CN110770252A (zh) | 抗p53抗体 | |
| CN118652334B (zh) | 一种靶向钙粘蛋白17的纳米抗体及其应用 | |
| CN117402243A (zh) | 抗Nectin-4抗体及其应用 | |
| CN114106177B (zh) | Cd22抗体及其应用 | |
| JP6707660B2 (ja) | 抗ポドカリキシン様タンパク質前駆体サブタイプ２モノクローナル抗体とその生成方法及び使用 | |
| WO2026007560A1 (zh) | 一种靶向成纤维活化蛋白α的纳米抗体及其应用 | |
| JP2024512260A (ja) | Ｖｅｇｆａ結合分子 | |
| AU2021446021A1 (en) | Anti-bcam antibody or antigen-binding fragment thereof | |
| CN114437232A (zh) | 一种细胞表面大分子定量展示系统及其制备方法和用途 | |
| JP2022504472A (ja) | Ｈｅｒ２結合四量体ポリペプチド | |
| WO2024120526A1 (zh) | 抗ilt4抗体及其制备方法和应用 | |
| CN110615841A (zh) | 抗人cd47单克隆抗体及其应用 | |
| CN118667005A (zh) | 抗pd-l1的纳米抗体及其用途 | |
| CN118667004A (zh) | 抗pd-l1的高阻断活性纳米抗体及其应用 | |
| CN101591396B (zh) | 一种抗erbB2人源抗体MIL-5及其应用 | |
| CN117700555B (zh) | 抗cll1的纳米抗体及其相关应用 | |
| CN117510636B (zh) | Gprc5d抗体及其应用 | |
| CN121426938A (zh) | 一种特异性结合新型冠状病毒核衣壳蛋白的抗体或其抗原结合片段及其应用 |